Search Within

Melanoma and Immunotherapeutics Service

Formats
  1. Journal Article (958)
  2. Meeting Abstract (774)
  3. Book Section (42)
  4. Editorial (32)
  5. Review (26)
  6. Research Letter (15)
  7. Guidelines (6)
  8. Correspondence (5)
  9. Conference Paper (4)
  10. Miscellaneous (3)
  11. Book Whole (2)
Groups
  1. Department of Medicine (1867)
  2. Solid Tumor Oncology Division (1867)
  3. GSK Faculty (1051)
  4. Melanoma Disease Management Team (788)
  5. Hematologic Malignancies, Division of (510)
  6. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (441)

More Groups

People
  1. Jedd Wolchok (905)
  2. Michael Postow (365)
  3. Taha Merghoub (365)
  4. Paul Chapman (326)
  5. Alexander Shoushtari (246)
  6. Margaret Callahan (198)

More People

Years
  1. 2025 (29)
  2. 2024 (46)
  3. 2023 (66)
  4. 2022 (125)
  5. 2021 (112)
  6. 2020 (122)

More Years

Publications
  1. Journal of Clinical Oncology (334)
  2. Journal for ImmunoTherapy of Cancer (131)
  3. Cancer Research (106)
  4. Clinical Cancer Research (91)
  5. Annals of Oncology (77)
  6. Proceedings of the American Association for Cancer Research Annual Meeting (43)

More Publications

Publishers
  1. American Society of Clinical Oncology (346)
  2. American Association for Cancer Research (275)
  3. Biomed Central Ltd (148)
  4. Elsevier Inc. (144)
  5. Oxford University Press (109)
  6. Nature Publishing Group (90)

More Publishers

Results (1867)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Pokemon protein characterization and expression in B and T-cell lymphomas
    Meeting Abstract

    Teruya-Feldstein, J.; Maeda, T.; Hobbs, R.; Merghoub, T.; Guernah, I.; Zelenent, A.; Pandolfi, P.
    Laboratory Investigation (2005)

    Fulltext@MSK | Save
  • Pokemon protein characterization and expression in B and T-cell lymphomas
    Meeting Abstract

    Teruya-Feldstein, J.; Maeda, T.; Hobbs, R.; Merghoub, T.; Guernah, I.; Zelenent, A.; Pandolfi, P.
    Modern Pathology (2005)

    Fulltext@MSK | Save
  • Variates of survival for stage IV uveal melanoma
    Meeting Abstract

    Rietschel, P.; Panageas, K.; Hanlon, C.; Patel, A.; Chapman, P. B.
    Journal of Clinical Oncology (2005)

    Fulltext@MSK | Save
  • Analysis of mutations in a tissue-specific gene that elicit autoimmunity and tumor immunity
    Meeting Abstract

    Preiss, S.; Engelhorn, M.; Noffz, G.; Guevara, J. A; Wolchok, J. D.; Houghton, A. N.
    FASEB Journal (2005)

    Fulltext@MSK | Save
  • DNA immunization against HER2/neu+ breast cancer: Evidence for a role of both antibody and T cell for optimal tumor eradication
    Meeting Abstract

    Orlandi, F.; Venanzi, F. M.; Concetti, A.; Yamauchi, J.; Wolchok, J. D.; Norton, L.; Houghton, A. N.; Gregor, P. D.
    FASEB Journal (2005)

    Fulltext@MSK | Save
  • Conditional inactivation of the proto-oncogene Pokemon results in block of differentiation in multiple hematopoietic lineages
    Meeting Abstract

    Maeda, T.; Merghoub, T.; Hobbs, R.; Dong, L.; Maeda, M.; Zelent, A.; Teruya-Feldstein, J.; Pandolfi, P. P.
    Blood (2005)

    Fulltext@MSK | Save
  • Phase III study of adjuvant vaccination with Bec2/bacille Calmette-Guerin in responding patients with limited-disease small-cell lung cancer (European Organisation for Research and Treatment of Cancer 08971-0897113; Silva Study)
    Journal Article

    Giaccone, G.; Debruyne, C.; Felip, E.; Chapman, P. B.; Grant, S. C.; Millward, M.; Thiberville, L.; D'Addario, G.; Coens, C.; Rome, L. S.; more...
    Journal of Clinical Oncology (2005)

    Fulltext@MSK | Save
  • How lymphotoxic is doseIntensiļ¬ed temozolomide? The glioblastoma experience - Reply
    Journal Article

    Su, Y. B.; Krown, S. E.; Livingston, P. O.; Wolchok, J. D.; Chapman, P. B.
    Journal of Clinical Oncology (2005)

    Fulltext@MSK | Save
  • Synthesis of selected LeY and KH-1 analogues: A medicinal chemistry approach to vaccine optimization
    Journal Article

    Spassova, M. K.; Bornmann, W. G.; Ragupathi, G.; Sukenick, G.; Livingston, P. O.; Danishefsky, S. J.
    Journal of Organic Chemistry (2005)

    Fulltext@MSK | Save
  • Thomsen-Friedenreich (TF) antigen as a target for prostate cancer vaccine: Clinical trial results with TF cluster (c)-KLH plus QS21 conjugate vaccine in patients with biochemically relapsed prostate cancer
    Journal Article

    Slovin, S. F.; Ragupathi, G.; Musselli, C.; Fernandez, C.; Diani, M.; Verbel, D.; Danishefsky, S.; Livingston, P.; Scher, H. I.
    Cancer Immunology, Immunotherapy (2005)

    Fulltext@MSK | Save